Mazur Leonard L has filed 18 insider transactions across 3 companies since April 2024.
Most recent transaction: a grant/award of 1700000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 89388 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.81% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 125490 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 1.14% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 125490 | $0.00 | 125,490.0000 | 11,006,896 | 9999.99% | 1.14% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 89388 | $0.00 | 89,388.0000 | 11,006,896 | 9999.99% | 0.81% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 800000 | $0.00 | 4,500,000.0000 | 68,053,607 | 21.62% | 1.18% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Purchase Common Stock) | 600000 | $0.00 | 3,215,000.0000 | 6,726,999 | 22.94% | 8.92% |
| Aug. 14, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 3137255 | $0.00 | 1,165,048.0000 | 6,954,278 | 72.92% | 45.11% |
| Aug. 14, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 3137255 | $0.00 | 4,302,303.0000 | 6,954,278 | 269.28% | 45.11% |
| Sept. 25, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 2234700 | $0.00 | 1,165,048.0000 | 6,954,278 | 65.73% | 32.13% |
| Sept. 25, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 2234700 | $0.00 | 3,399,748.0000 | 6,954,278 | 191.81% | 32.13% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 3700000 | $0.00 | 3,700,000.0000 | 67,500,000 | 9999.99% | 5.48% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 1233333 | $0.00 | 1,233,333.0000 | 67,500,000 | 9999.99% | 1.83% |
| Aug. 9, 2024 | Canton Strategic Holdings, Inc. | $CNTN | Mazur Leonard L | Director | A | Options (right to buy) | 2353 | $0.00 | 27,353.0000 | 0 | 9.41% | 0.00% |
| April 3, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 1165048 | $0.00 | 6,537,003.0000 | 6,362,890 | 21.69% | 18.31% |
| April 3, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 1165048 | $0.00 | 5,371,955.0000 | 6,362,890 | 17.82% | 18.31% |